ORASURE TECHNOLOGIES INC
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
OSUR$3.33-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| OPERATING ACTIVITIES: | |||
| Net (loss) income | $(68,731) | $(19,500) | $53,655 |
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities | |||
| Stock-based compensation | 10,147 | 11,920 | 10,729 |
| Depreciation and amortization | 10,192 | 10,872 | 20,936 |
| Loss on impairments | — | 4,392 | 10,829 |
| Other non-cash amortization | (222) | (564) | 3 |
| Provision for credit losses | (65) | 71 | (462) |
| Unrealized foreign currency loss (gain) | 365 | (263) | 103 |
| Interest expense on finance leases | 8 | 22 | 51 |
| Loss on equity investment | 2,344 | 1,700 | — |
| Deferred income taxes | 1,853 | (657) | 102 |
| (Gain) loss on sale of fixed assets | (725) | 563 | — |
| Change in the estimated fair value of acquisition-related contingent consideration | 4,570 | — | (99) |
| Payment of acquisition-related contingent consideration | — | — | (19) |
| Changes in assets and liabilities: | |||
| Accounts receivable | 1,949 | 15,872 | 31,116 |
| Inventories | 3,562 | 13,096 | 48,228 |
| Prepaid expenses and other assets | (2,368) | 4,089 | (2,499) |
| Accounts payable | (1,720) | (7,577) | (26,976) |
| Deferred revenue | (1,519) | (219) | (730) |
| Accrued expenses and other liabilities | (8,663) | (6,443) | (3,384) |
| Net cash (used in) provided by operating activities | (49,023) | 27,374 | 141,583 |
| INVESTING ACTIVITIES: | |||
| Purchases of short-term investments | — | (53,244) | (74,652) |
| Proceeds from maturities and redemptions of investments | — | 53,052 | 102,440 |
| Purchase of equity method investee | — | (30,000) | — |
| Acquisition of business, net of cash acquired | (3,613) | (5,037) | — |
| Proceeds from sale of assets | 1,000 | — | — |
| Purchases of property and equipment | (4,197) | (3,797) | (5,802) |
| Purchase of property and equipment under government contracts | — | — | (4,501) |
| Proceeds from funding under government contracts | — | — | 48,669 |
| Net cash (used in) provided by investing activities | (6,810) | (39,026) | 66,154 |
| FINANCING ACTIVITIES: | |||
| Cash payments for lease liabilities | (61) | (842) | (1,345) |
| Proceeds from exercise of stock options | — | 214 | 269 |
| Repurchase of common stock | (15,040) | — | — |
| Payment of acquisition-related contingent consideration | — | — | (46) |
| Payment of taxes related to net share settlement of equity awards | (1,843) | (3,548) | (1,901) |
| Net cash used in financing activities | (16,944) | (4,176) | (3,023) |
| EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH | 4,292 | (6,816) | 1,713 |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (68,485) | (22,644) | 206,427 |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 267,763 | 290,407 | 83,980 |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | $199,278 | $267,763 | $290,407 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.